Persistent cramps are a symptom of colorectal cancer – but is a CURE on horizon? 

Colorectal cancer symptoms include a change in bowel habits, diarrhoea or constipation.

Finding blood in your stool, or persistent abdominal cramps, could also be a sign of the cancer.

While the symptoms are very common, the NHS recommends seeing your GP if the they last more than four weeks.

Most people with symptoms, however, don’t have bowel cancer.

Until now, radioimmunotherapy - radiation treatment for cancers - have had limited success, according to the researchers.

But, the treatment uses three-steps to find and destroy colorectal cancer cells, scientists said.

Trials in mice proved to be 100 per cent effective, and the treatment could easily be used in humans, they added.

More than 40,000 new cases of bowel cancer were reported in the UK during 2014, including almost 16,000 deaths.

While the study assessed the treatment’s effectiveness at combatting colorectal cancer, it could be used for a number of other cancers, too.

“If clinically successful, our approach will expand the repertoire of effective treatments for oncologic patients,” said Steven Larson and Sarah Cheal, of Memorial Sloan Kettering Cancer Center.

“The system is designed as a ‘plug and play’ system, which allows for the use of many antibodies.

“It’s applicable, in principle, to virtually all solid and liquid tumours in man.”

The treatment uses a theranostic agent - a chemical which hunts down and kills any cancer cells.

It was used on mice that needed treatment for colorectal cancer.

All of the mice had no traces of cancer after treatment, researchers confirmed.

There was also no detectable radiation damage to their vital organs, including bone marrow and kidneys.

“There is a huge unmet need in oncology, especially for the solid tumours, for curative treatments for advanced disease,” said the researchers.

“This includes, colon, breast, pancreas, melanoma, lung, and oesophageal, to name a few.”

Colorectal cancer, also known as bowel cancer, is the fourth most common cancer in the UK, according to Cancer Research UK.

One in 14 men, and one in 19 women, will be diagnosed with the condition in their lifetime.